Walter and Eliza Hall Institute of Medical Research
Kylie is one of those rare individuals who combine an outstanding commitment to clinical medicine and direct one on one patient care, with a longer term vision for improving general patient outcomes through research. Kylie has worked on a project that examines the molecular regulations of platelet lifespan, with her colleagues. This work was published in the prestigious medical research journal “Cell”.
One of the most exciting potential benefits of Kylie’s research is the possibility of extending the lifespan of stored platelets in the blood bank. This has very major commercial potential and the potential to save many lives by increasing the availability of platelets for transfusion.
Kylie’s results have been patented and licensed to a Victorian Biotechnology Company MuriGen which has chosen to invest considerable resources in the commercial development of her research.